Details for 2019169275

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019169275

EP Publication Number

3533792

E-Number

1389688

Language

PCT Number

Publication Date

04.09.2019 A

05.05.2021 B1

Registration Date

05.05.2021

AT Publication Date

15.05.2021

Application Date

04.06.2013

Registration Number

Priorities

07.06.2012

201261656888 P

IPC

C07D 401/04 20060101AFI20190527BHEP

Maximum Duration of Protection

04.06.2033

Owner

Aragon Pharmaceuticals, Inc.10990 Wilshire Blvd. Suite 440 Los Angeles, CA 90024US

Sloan Kettering Institute For Cancer Research1275 York Avenue New York, NY 10065US

Representative

Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

DILHAS, AnnaHäsingerstr. 32 4055 BaselCH

OUERFELLI, Ouathek2077 Center Avenue, Apt. 3J Fort Lee, NJ 07024US

SMITH, Nicholas D.1204 Beryl Street San Diego, CA 92109US

HERBERT, Mark R.4180 Amoroso Street San Diego, CA 92111US

Information about Fees